The Valley Desk

NCT01466595 · Interventional trial

Rifaximin as a Modulator of Microbial Translocation and Immune Activation

Overall registry status Completed

Phase 2

Conditions HIV-1 Infection

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov